XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://xconomy.com/boston/2020/05/29/forma-therapeutics-eyes-ipo-to-advance-sickle-cell-prostate-cancer-drugs/60%Monthly2020-05-30 02:30
https://xconomy.com/boston/2020/05/29/after-inking-bristol-myers-pact-repare-therapeutics-sets-sights-on-ipo/60%Monthly2020-05-30 14:28
https://xconomy.com/national/2020/05/29/abbvie-wins-first-fda-approval-of-drug-to-treat-uterine-fibroid-bleeds/60%Monthly2020-05-29 22:26
https://xconomy.com/national/2020/05/29/bio-roundup-asco-opens-merck-takes-on-covid-evofems-approval-more/60%Monthly2020-05-29 13:59
https://xconomy.com/europe/2020/05/29/ipsen-taps-sanofis-vaccines-executive-david-loew-for-ceo-role/60%Monthly2020-05-29 17:21
https://xconomy.com/seattle/2020/05/28/variant-emerges-with-16m-to-find-outlier-humans-to-reveal-new-drugs/60%Monthly2020-05-29 04:15
https://xconomy.com/boston/2020/05/28/flagship-pioneering-taps-chouraqui-as-ceo-partner-ceo-of-cellarity/60%Monthly2020-05-28 23:29
https://xconomy.com/new-york/2020/05/28/immunomedics-president-ceo-harout-semerjian-steps-down/60%Monthly2020-05-28 14:00
https://xconomy.com/national/2020/05/28/fda-welcomes-variety-of-phase-2-3-trial-designs-for-covid-19-therapies/60%Monthly2020-05-28 01:31
https://xconomy.com/san-francisco/2020/05/28/ngm-names-castlights-nolan-mangini-as-its-chief-financial-officer/60%Monthly2020-05-28 14:11
https://xconomy.com/new-york/2020/05/28/applied-therapeutics-taps-chuck-silberstein-as-chief-financial-officer/60%Monthly2020-05-28 14:15
https://xconomy.com/san-francisco/2020/05/27/gileads-delaney-jumps-to-assembly-bio-as-chief-scientific-officer/60%Monthly2020-05-27 22:31
https://xconomy.com/seattle/2020/05/27/former-aimmune-exec-stephen-dilly-named-sierra-oncologys-new-ceo/60%Monthly2020-05-27 22:59
https://xconomy.com/seattle/2020/05/27/abcellera-raises-105m-to-advance-antibody-discovery-operations/60%Monthly2020-05-27 21:40
https://xconomy.com/boston/2020/05/27/webinars-simple-signaling-reporter-assays-reducing-attrition-drug-induced-liver-injury/60%Monthly2020-06-01 15:34
https://xconomy.com/san-francisco/2020/05/27/gilead-gains-foothold-in-solid-tumors-with-375m-10-year-arcus-bio-pact/60%Monthly2020-05-27 20:41
https://xconomy.com/new-york/2020/05/27/merck-outlines-covid-19-ambitions-with-buyout-deal-collaborations/60%Monthly2020-05-27 14:16
https://xconomy.com/san-francisco/2020/05/26/insitro-adds-143m-to-fuel-machine-learning-driven-drug-development/60%Monthly2020-05-28 19:44
https://xconomy.com/san-diego/2020/05/26/viacyte-adds-27m-to-move-ahead-trio-of-stem-cell-diabetes-treatments/60%Monthly2020-05-29 13:27
https://xconomy.com/boston/2020/05/26/covid-19-sparks-new-opportunities-for-digital-health-companies/60%Monthly2020-05-26 21:17
https://xconomy.com/national/2020/05/22/generation-bio-leads-a-trio-of-biotech-companies-aiming-for-the-nasdaq/60%Monthly2020-05-29 13:38
https://xconomy.com/national/2020/05/22/fda-approves-evofems-on-demand-non-hormonal-birth-control-gel/60%Monthly2020-05-29 05:30
https://xconomy.com/national/2020/05/22/bio-roundup-mrna-vaccine-data-rise-of-rallybio-roches-protein-play-more/60%Monthly2020-05-22 15:44
https://xconomy.com/boston/2020/05/22/amag-pharma-sells-off-womens-health-product-in-planned-divestment/60%Monthly2020-05-22 12:42
https://xconomy.com/boston/2020/05/21/sunovion-drug-gets-fda-nod-for-treating-parkinsons-off-episodes/60%Monthly2020-05-22 00:25
https://xconomy.com/boston/2020/05/21/hotspot-adds-65m-to-steer-allosteric-medicines-into-the-clinic/60%Monthly2020-05-21 18:21
https://xconomy.com/san-diego/2020/05/20/vividion-gets-135m-in-collaboration-with-roche-on-protein-degradation/60%Monthly2020-05-21 01:24
https://xconomy.com/san-francisco/2020/05/20/applied-molecular-plots-ipo-to-back-transport-of-biologic-drugs-to-gut/60%Monthly2020-05-20 20:20
https://xconomy.com/national/2020/05/20/explore-san-diegos-precision-medicine-and-genomics-sector-in-xconomys-new-podcast-and-special-report/60%Monthly2020-05-20 16:31
https://xconomy.com/san-francisco/2020/05/20/with-30m-octant-launches-synthetic-bio-search-for-multi-target-drugs/60%Monthly2020-05-20 10:06
https://xconomy.com/new-york/2020/05/19/oligomerix-appoints-ex-pfizer-exec-erhardt-as-chief-medical-officer/60%Monthly2020-05-19 19:18
https://xconomy.com/san-diego/2020/05/19/mirati-names-synthorxs-joseph-leveque-as-new-chief-medical-officer/60%Monthly2020-05-19 19:54
https://xconomy.com/new-york/2020/05/19/merck-spinoff-organon-taps-ex-allergan-execs-walsh-stahler-for-c-suite/60%Monthly2020-05-19 17:14
https://xconomy.com/raleigh-durham/2020/05/19/tevas-tushar-shah-joins-liquidia-as-chief-medical-officer/60%Monthly2020-05-19 14:43
https://xconomy.com/san-diego/2020/05/19/amplyx-adds-cash-from-pfizer-adage-as-funding-round-tops-90m/60%Monthly2020-05-19 00:33
https://xconomy.com/new-york/2020/05/19/rallybio-lands-145m-to-alter-course-of-fnait-and-more-rare-diseases/60%Monthly2020-05-19 04:51
https://xconomy.com/san-francisco/2020/05/18/ardelyx-adds-tolmars-rodriguez-as-its-first-chief-commercial-officer/60%Monthly2020-05-19 13:29
https://xconomy.com/boston/2020/05/18/early-covid-19-vaccine-data-sets-up-moderna-for-next-stages-of-testing/60%Monthly2020-05-21 18:13
https://xconomy.com/boston/2020/05/18/akcea-therapeutics-taps-michael-price-as-its-chief-financial-officer/60%Monthly2020-05-18 18:41
https://xconomy.com/national/2020/05/16/antibiotic-development-hhs-not-yet-sold-on-pull-incentives/60%Monthly2020-05-15 22:24
https://xconomy.com/boston/2020/05/15/deciphera-pharmaceuticals-wins-early-fda-nod-for-gi-cancer-treatment/60%Monthly2020-05-15 23:48
https://xconomy.com/new-york/2020/05/15/adcs-233m-ipo-brings-it-to-nyse-with-cancer-drug-launch-on-horizon/60%Monthly2020-05-15 18:24
https://xconomy.com/national/2020/05/15/bio-roundup-fda-dings-bms-genfits-fall-alexions-activist-more/60%Monthly2020-05-15 15:36
https://xconomy.com/new-york/2020/05/15/from-overseas-legend-biotech-and-calliditas-therapeutics-eye-the-nasdaq/60%Monthly2020-05-29 13:27
https://xconomy.com/new-york/2020/05/14/biotech-mapmaker-immunai-launches-with-20m-to-chart-the-immune-system/60%Monthly2020-05-14 16:00
https://xconomy.com/new-york/2020/05/14/boehringer-ingelheim-acquires-northern-biologics-preclinical-pipeline/60%Monthly2020-05-14 08:19
https://xconomy.com/boston/2020/05/13/artax-biopharma-names-joseph-lobacki-as-new-chief-executive-officer/60%Monthly2020-05-13 21:03
https://xconomy.com/san-diego/2020/05/13/gossamer-announces-resignation-of-chief-medical-officer-jakob-dupont/60%Monthly2020-05-13 18:17
https://xconomy.com/new-york/2020/05/13/bcma-delay-fda-refuses-review-of-bristol-drug-asks-for-more-info/60%Monthly2020-05-29 13:27
https://xconomy.com/boston/2020/05/13/quralis-hauls-in-42m-to-move-new-als-therapies-into-human-testing/60%Monthly2020-05-13 03:25
https://xconomy.com/san-diego/2020/05/13/oncology-biotech-ceo-activates-latent-viral-side-against-covid-19/60%Monthly2020-05-12 23:44
https://xconomy.com/san-francisco/2020/05/12/pliant-pushes-forward-with-ipo-plans-to-back-fibrosis-drug-studies/60%Monthly2020-05-12 18:52
https://xconomy.com/boston/2020/05/12/celsius-therapeutics-names-jeanne-magram-chief-scientific-officer/60%Monthly2020-05-12 15:13
https://xconomy.com/san-francisco/2020/05/12/bolt-bio-picks-sunesiss-william-quinn-as-chief-financial-officer/60%Monthly2020-05-12 14:56
https://xconomy.com/boston/2020/05/12/xcelerating-life-sciences-biopharma-digital-health/60%Monthly2020-05-13 20:22
https://xconomy.com/national/2020/05/11/genfit-contender-in-heated-nash-drug-race-fails-in-phase-3-study/60%Monthly2020-05-12 03:16
https://xconomy.com/boston/2020/05/11/amag-pharma-cuts-140-jobs-amid-restructuring-covid-19-disruptions/60%Monthly2020-05-11 21:40
https://xconomy.com/san-francisco/2020/05/11/myokardias-heart-drug-shines-in-phase-3-fda-filing-planned-for-2021/60%Monthly2020-05-11 21:09
https://xconomy.com/boston/2020/05/11/dyno-debuts-with-plan-partnerships-for-better-gene-therapy-vectors/60%Monthly2020-05-29 13:37
https://xconomy.com/indiana/2020/05/08/eli-lilly-gets-edge-in-the-ret-race-with-fda-nod-for-cancer-drug/60%Monthly2020-05-29 13:39
https://xconomy.com/national/2020/05/08/2020-national-xconomy-awards-finalists-will-be-announced-on-june-22/60%Monthly2020-05-08 17:16
https://xconomy.com/national/2020/05/08/bio-roundup-acquisitive-alexion-crispr-on-covid-c-diff-success-more/60%Monthly2020-05-08 16:08
https://xconomy.com/national/2020/05/08/ayalas-ipo-raises-55m-to-test-two-former-bristol-myers-cancer-drugs/60%Monthly2020-05-08 15:32
https://xconomy.com/san-diego/2020/05/07/trovagene-rebrands-as-cardiff-oncology-promotes-longtime-exec-to-ceo/60%Monthly2020-05-08 03:46
https://xconomy.com/boston/2020/05/07/gemini-therapeutics-names-ex-achillion-exec-marc-uknis-chief-medical-officer/60%Monthly2020-05-07 21:09
https://xconomy.com/boston/2020/05/07/akcea-adds-vertexs-carla-poulson-as-chief-human-resources-officer/60%Monthly2020-05-07 17:32
https://xconomy.com/boston/2020/05/07/fogpharma-appoints-tony-gibney-as-chief-financial-business-officer/60%Monthly2020-05-07 17:04
https://xconomy.com/new-york/2020/05/07/ptc-therapeutics-to-acquire-censa-pharma-for-mid-stage-rare-disease-drug/60%Monthly2020-05-29 13:38
https://xconomy.com/national/2020/05/06/novartis-drug-wins-fda-approval-for-lung-cancers-with-specific-mutation/60%Monthly2020-05-07 01:46
https://xconomy.com/national/2020/05/06/astrazeneca-diabetes-drug-gets-fda-ok-for-reducing-heart-health-risks/60%Monthly2020-05-07 00:36
https://xconomy.com/san-francisco/2020/05/06/kezar-life-sciences-taps-noreen-roth-henig-as-chief-medical-officer/60%Monthly2020-05-06 19:51
https://xconomy.com/boston/2020/05/06/ventus-launches-with-60m-to-shine-light-on-innate-immune-system-drugs/60%Monthly2020-05-06 17:07
https://xconomy.com/national/2020/05/06/encouraging-signals-for-new-cancer-cell-therapy-strategies/60%Monthly2020-05-29 13:27
https://xconomy.com/san-diego/2020/05/05/kura-narrows-pipeline-after-strategic-review-prompted-by-covid-19/60%Monthly2020-05-06 03:55
https://xconomy.com/boston/2020/05/05/alexion-pharma-boosts-blood-drug-lineup-with-1-4b-deal-for-portola/60%Monthly2020-05-06 20:04
https://xconomy.com/san-diego/2020/05/05/covid-19-and-fungal-superinfections-the-deadly-perfect-storm/60%Monthly2020-05-05 00:00
https://xconomy.com/national/2020/05/04/arrowhead-pharmas-chief-operating-officer-bruce-given-retires/60%Monthly2020-05-04 22:42
https://xconomy.com/new-york/2020/05/04/stemline-slated-for-acquisition-by-menarini-in-deal-worth-up-to-677m/60%Monthly2020-05-04 23:53
https://xconomy.com/boston/2020/05/04/backed-by-100m-praxis-aims-to-turn-epilepsy-research-into-new-neuro-drugs/60%Monthly2020-05-23 15:10
https://xconomy.com/europe/2020/05/01/pfizer-pays-valneva-130m-for-a-bite-at-a-lyme-disease-vaccine/60%Monthly2020-05-01 23:44
https://xconomy.com/national/2020/05/01/fda-authorizes-emergency-use-of-gileads-remdesivir-for-severe-covid-19/60%Monthly2020-05-02 00:52
https://xconomy.com/boston/2020/05/01/lyra-therapeutics-ipo-raises-56m-for-tests-of-tech-for-runny-noses/60%Monthly2020-05-01 16:48
https://xconomy.com/national/2020/05/01/bio-roundup-remdesivir-data-erascas-200m-a-new-fda-nod-more/60%Monthly2020-05-01 14:59